Quantbot Technologies’s Enliven Therapeutics ELVN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$89.8K	Buy	4,477 +1,434	+47%	+$28.8K	﹤0.01%	1419
2025 Q1	$59.9K	Buy	+3,043	New	+$59.9K	﹤0.01%	1301